Ethics of early clinical trials in regenerative medicine in transplantation

 

Bio-artificial organs and bio-engineered or bio-printed tissues for transplantation in humans are rapidly being developed. It is anticipated that some applications will be ready for clinical testing in the near future. How can first-in-human clinical trials be conducted in a safe and responsible manner? What are ethical points to consider for early clinical trials of regenerative medicine in transplantation? This workshop brings together experts in the fields of regenerative medicine and ethics to discuss these ethical challenges.
KEYNOTE SPEAKER

 

Professor Jonathan Kimmelman, McGill University

Director of Biomedical Ethics Unit

Author of Gene Transfer and the Ethics of First-in-Human Trials: Lost in Translation

SHOWCASES OF REGENERATIVE MEDICINE APPLICATIONS Insights from 3 projects funded through EU Horizon 2020

‘Regenerative medicine: From new insights to new applications’

BRAVE, OrganTrans & VANGUARD

PANEL DISCUSSION

 

Moderated by Eline Bunnik & Emma Massey

Panel members include

Jonathan Kimmelman, Antonia Cronin & Ekaterine Berishvili

Register online, meeting is open to the public. Attendance is free. Registration is required.

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

Feb 03 2022

Time

CET
4:00 pm - 6:00 pm

More Info

Register online
Register online